1,2,3,4-tetrahydroisoquinoline has been researched along with Nerve Degeneration in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (50.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
GoĊembiowska, K; Lorenc-Koci, E; Wardas, J | 1 |
Dostert, P; Nagatsu, T; Naoi, M; Yoshida, M | 1 |
2 other study(ies) available for 1,2,3,4-tetrahydroisoquinoline and Nerve Degeneration
Article | Year |
---|---|
1,2,3,4-Tetrahydroisoquinoline protects terminals of dopaminergic neurons in the striatum against the malonate-induced neurotoxicity.
Topics: Analysis of Variance; Animals; Dopamine; Energy Metabolism; Male; Malonates; Medial Forebrain Bundle; Neostriatum; Nerve Degeneration; Neurons; Neuroprotective Agents; Presynaptic Terminals; Rats; Rats, Wistar; Succinate Dehydrogenase; Tetrahydroisoquinolines | 2005 |
N-methylated tetrahydroisoquinolines as dopaminergic neurotoxins.
Topics: Animals; Brain; Cell Death; Culture Techniques; Dopamine; Humans; Isoquinolines; Methylation; Methyltransferases; Monoamine Oxidase; Nerve Degeneration; Parkinson Disease; Rats; Receptors, Dopamine; Substantia Nigra; Tetrahydroisoquinolines | 1993 |